Skip to content
2000
Volume 7, Issue 2
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

This review highlights structural diversity of antimitotic agents. In particular, we emphasized current antimitotic therapies based on modulation of microtubule dynamics. With several successful anticancer drugs on the market and numerous compounds in clinical developments, tubulin-binding agents remain among the most important categories of anticancer agents. Compounds targeting mitotic kinases and kinesins are also discussed.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152007780058650
2007-03-01
2025-04-01
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/187152007780058650
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test